Telstar Sublime is a finalist at CPHI Pharma Awards 2023

The pioneering single-use real-time sublimation front monitoring system for GMP freeze-dryers has been shortlisted in the Accelerating Innovation category of CPHI’s Pharma Awards 2023. The winners will be revealed at the opening day of CPHI Barcelona at the Fira Barcelona, which is running from 24-26 October.

The 2023 awards mark the 20th anniversary of the CPHI Pharma Awards, which began in 2004. These awards have traditionally celebrated pharma’s brightest individuals and companies, and winners have been selected for their contributions to driving the industry forward through people, products, and performance. This year’s edition has introduced three new categories to reflect the wave of current innovation that has engulfed the industry.

The shortlist of finalists, which was narrowed down from more than 180 entries across 12 categories that cover innovations across the full pharmaceutical supply chain, include companies that led by example in sustainable manufacturing and manufacturers and innovators that developed new technologies to advance drug discovery, development, and manufacturing, as well as honouring transformational digital solutions of the future.

Among the best for two successive years

Telstar has been shortlisted for CPHI Awards for the second consecutive year. In 2022, the company was a finalist for their innovative Lyogistics Smart Format, a new automatic vial format change system for freeze-drying loading and unloading processes. We are immensely proud and grateful for this, a two-fold merit that underlines not only the innovative capacity of the Telstar brand but also the recognition of their contributions, as valuable assets, towards the positive progress of the life science markets, particularly the pharmaceutical industry.